Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Pre-Stabilisation Period Announcement

6th Dec 2017 07:15

RNS Number : 4899Y
Barclays Capital Securities Limited
06 December 2017
 

06 December 2017

Not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Canada, Japan or South Africa or any jurisdiction in which such distribution would be unlawful.

Sabre Insurance Group plc

Pre-Stabilisation Period Announcement

Barclays Bank PLC ('Barclays') (Ben West; telephone: +44 20 7773 9531) hereby gives notice that as Stabilising Coordinator, the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052, with the aim of supporting the market price of such securities during the stabilisation period.

 

The securities:

Issuer:

Sabre Insurance Group plc

Aggregate nominal amount/Offering size:

125,000,000 Ordinary Shares (excluding the over-allotment option)

Description:

Ordinary Shares in Sabre Insurance Group plc with a nominal value of £0.001. ISIN: GB00BYWVDP49

Offer price;

 230p

Stabilisation:

Stabilisation Manager:

Barclays Capital Securities Limited, 5 The North Colonnade, Canary Wharf, London, E14 4BB, United Kingdom

Stabilisation period expected to start on:

 6th December 2017 (approximately 08.00 a.m.)

Stabilisation period expected to end no later than:

 5th January 2018 (close of business)

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law up to a maximum size of 12,500,000 Ordinary Shares

Existence, maximum size, exercise period and conditions of use of Over-allotment Option:

In connection with the IPO, the Stabilising Manager may, for stabilisation purposes, over-allot Shares up to a maximum of 12,500,000 Ordinary Shares

Stabilisation Trading Venue:

London Stock Exchange

 

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Order) or who are high net worth persons falling within Article 49 of the Order and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities to which this announcement relates which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement is only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except to "qualified institutional buyers" as defined in, and in reliance on, Rule 144A under the Securities Act or another exemption from, or transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAMMMGZMKRGNZZ

Related Shares:

Sabre Insur
FTSE 100 Latest
Value8,608.48
Change-26.32